Carregant...
Treatment with Botulinum toxin A in a total population of children with cerebral palsy - a retrospective cohort registry study
BACKGROUND: Botulinum toxin A (BTX-A) has been used to reduce spasticity in children with cerebral palsy (CP) for decades. The purpose of this study was to analyze to what extent BTX-A treatment was used to treat spasticity in a total population of children with CP. We investigated 1) the use of BTX...
Guardat en:
| Publicat a: | BMC Musculoskelet Disord |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5725838/ https://ncbi.nlm.nih.gov/pubmed/29228927 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12891-017-1880-y |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|